These data are in agreement with most of the recently published meta-analyses that demonstrated an association between CXCR4 expression and metastatic status in renal cell carcinoma, breast cancer, gastric cancer, colorectal cancer and esophageal cancer [47, 50–53]. This evidence concerns the gene CXCR4 and breast cancer.